Your Location:
Home >
Browse articles >
Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia
RESEARCH | Updated:2025-12-13
    • Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia

    • “Reporting on the latest research in the field of benign prostatic hyperplasia (BPH), experts have established a novel link between microbial presence and prostatic fibrosis. The study, which provides solutions to address the ineffectiveness of current BPH treatments, verified that Salmonella enterica promotes prostatic fibrosis through ALKBH5-m6A-GPX4-mediated ferroptosis, laying a foundation for the construction of new therapeutic targets and personalized strategies.”
    • Cong Zhu , Lu-Yao Li , Ming-Hui Shi , Cheng Fang , Lu Yang , Ting Li , Fei Li , Shi-Song Yang , Tian-Kun Wang , Dao-Jing Ming , Tong Deng , Hao-Yue Sun , Wen-Ting Li , Jia Zhang , Yu-Sen Zhang , Zhi-Yuan Jian , Chang-Jiang Qin , Shuang-Ying Wang , Xian-Tao Zeng
    • Military Medical Research Vol. 12, Issue 9, Pages: 1350-1368(2025)
    • DOI: 10.1186/s40779-025-00614-2     

      CLC:
    • Accepted:29 April 2025 ,

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 7 ) Tabs( 0 )

  • References

  • Publication Info

  • Metrics

65

Views

23

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
P. gingivalis in oral-prostate axis exacerbates benign prostatic hyperplasia via IL-6/IL-6R pathway
GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
Expression of transforming growth factor β receptors in CCI4, -induced cirrhotic liver in rats
Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Related Author

Xian-Tao Zeng
Shuang-Ying Wang
Chang-Jiang Qin
Zhi-Yuan Jian
Xian-Tao Zeng
Yu Fan
Tong-Zu Liu
Hang Zheng

Related Institution

Department of Urology, Institute of Urology, Peking University First Hospital, Peking University, The National Urological Cancer Center of China
Evidence-Based Medicine Center, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine
Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University
Department of Urology, Wuhan Third Hospital, Tongren Hospital of Wuhan University
Department of Forensic Medicine, Zhongnan Hospital of Wuhan University